Riskpilot← Back to searchSign inGet full accessCERCELL A/S
A/SActiveCVR 31940346Nørrelundvej 10Manufacture of medical and dental instruments and supplies · NACE 3250Est. 200920 employeeswww.cercell.com
Revenue 2025
DKK 10,8M
+4% vs 2024
EBITDA margin
13.2%
+137% vs 2024
Equity ratio
77.6%
Financial strength
Net profit 2025
DKK 1M
+139% vs 2024
| Revenue | DKK 10,8M | +4% |
| EBITDA | DKK 1,4M | +137% |
| Net profit | DKK 1M | +139% |
| Total assets | DKK 13,8M | +27% |
| Equity | DKK 10,7M | +10% |
| Employees | 20 | — |
Legal name
CERCELL A/S
CVR number
31940346
Legal form
Aktieselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
1. januar 2009
Share capital
DKK 475.000
Employees
20 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af bestyrelsen og direktionen i forening.
Company purpose
Selskabets formål er at drive industriel forsknings- og fremstillingsvirksomhed samt handel med produktionsanlæg til medicinfremstilling og hermed forbunden virksomhed.
Address
Nørrelundvej 10
Phone
+4544115400
Email
info@cercell.com
Website
www.cercell.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 296 | 469 | 250 | 1.617 | 2.441 | 1.775 | 2.375 | 3.484 | 5.089 | 11.744 | 15.898 | 12.650 | 10.322 | 10.765 |
| Staff expenses | -295 | -467 | -247 | -1.594 | -2.372 | -1.588 | -2.130 | -3.414 | -4.674 | -9.361 | -9.003 | -10.855 | -9.659 | -9.313 |
| EBITDA | 1 | 2 | 3 | 23 | 68 | 187 | 245 | 27 | 162 | 2.282 | 6.381 | 1.438 | 600 | 1.420 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -9 | -16 | -21 | -36 | -63 | -140 |
| EBIT | 1 | 2 | 3 | 23 | 68 | 187 | 245 | 27 | 153 | 2.266 | 6.360 | 1.403 | 537 | 1.280 |
| Net financials | 2 | 0 | 15 | 12 | -1 | -0 | 0 | 20 | 26 | -10 | -34 | -45 | 11 | 22 |
| Profit before tax | 3 | 2 | 19 | 35 | 68 | 187 | 245 | 47 | 179 | 2.256 | 6.326 | 1.357 | 548 | 1.302 |
| Tax | -0 | -0 | 8 | 5 | 15 | 41 | 54 | 14 | 40 | 498 | 1.397 | 309 | 123 | 285 |
| Net profit | 3 | 2 | 11 | 29 | 53 | 145 | 191 | 33 | 139 | 1.758 | 4.929 | 1.048 | 425 | 1.016 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 136 | 853 | 1.065 | 1.753 | 1.968 | 1.384 | 2.748 | 4.150 | 4.682 | 7.187 | 14.820 | 10.955 | 10.888 | 13.824 |
| Equity | 127 | 130 | 141 | 170 | 223 | 368 | 559 | 2.154 | 2.293 | 4.051 | 8.237 | 9.285 | 9.710 | 10.726 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 72 | 285 | 285 | 285 | 285 | 250 | 250 |
| Short-term debt | 9 | 723 | 925 | 1.583 | 1.745 | 1.016 | 2.177 | 1.924 | 2.104 | 2.850 | 6.298 | 1.385 | 928 | 2.848 |
| Total debt | 9 | 723 | 925 | 1.583 | 1.745 | 1.016 | 2.177 | 1.996 | 2.389 | 3.136 | 6.583 | 1.670 | 1.178 | 3.098 |
EBITDA margin
13.2%
This company
15.8%
Market median
-16% vs market
20122025
Equity ratio
77.6%
This company
38.2%
Market median
+103% vs market
20122025
Return on equity
9.5%
This company
18.4%
Market median
-48% vs market
20122025
Net profit margin
9.4%
This company
8.1%
Market median
+16% vs market
20122025
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
20122025
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FP Management | Management | 2023 | — | — |
KR Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2010 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CERCELL A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Flemming Petersen | Management | 0 companies |
| Kevin Robert Klejn | Chief Executive Officer | 0 companies |
| Lise Abildgaard Ryberg | Board of Directors | 0 companies |
| Per Stobbe | Board of Directors | 0 companies |
| Jens Erik Stovgaard | Chairman | 0 companies |
| August Kisling Stobbe | Board of Directors | 0 companies |
| Peter Mosegaard | Chairman | 0 companies |